GGrantScoutHQCreate alert

Curated topic

Health Grants for Small Businesses

Health, biomedical and care-delivery opportunities that include small businesses in recorded eligibility.

370 current opportunities · showing 1–24

OPENHealth & Medical

Advancing innovation in accelerated cancer diagnosis

UK Government

Description Innovate UK, on behalf of the Office for Life Sciences’ (OLS) Cancer Healthcare Goals programme, will invest up to £25.4 million in innovative CR&D projects. This funding will be to support the clinical validation and evaluation of early cancer diagnostic technologies and devices. This is subject to a suffi

Deadline
Oct 29, 2026
Funding
See official notice
Check fit and official source →
OPENSmall Business & Startups

CoSTAR Showcase Labs: Createch infrastructure and commercialisation (Grant)

UK Government

Word limit: 550In plain English, provide a summary we can use to identify the most suitable experts to assess your application. We usually make this summary publicly available on external-facing websites, therefore do not include any confidential or sensitive information. Make it suitable for a variety of readers, for e

Deadline
Oct 30, 2026
Funding
See official notice
Check fit and official source →
OPENSmall Business & Startups

CoSTAR Satellite Labs: Accessible creative R&D infrastructure (Grant)

UK Government

Word limit: 550In plain English, provide a summary we can use to identify the most suitable experts to assess your application. We usually make this summary publicly available on external-facing websites, therefore do not include any confidential or sensitive information. Make it suitable for a variety of readers, for e

Deadline
Oct 30, 2026
Funding
See official notice
Check fit and official source →
OPENHealth & Medical

GREGoRi Innovation Projects (U01 Clinical Trial Optional)

National Institutes of Health

The Genomics Research to Elucidate the Genetics of Rare Diseases:innovation (GREGoRi) initiative seeks to accelerate a paradigm shift in rare disease diagnosis by reimagining the tools, molecular technologies and analytical approaches used to identify the causal gene(s) and/or variant(s) underlying

Deadline
Oct 31, 2026
Funding
Estimated total program funding: $7,500,000
Check fit and official source →
OPENHealth & Medical

GREGoRi Technology Integration Center (U01, Clinical Trials Optional)

National Institutes of Health

The Genomics Research to Elucidate the Genetics of Rare Diseases:innovation (GREGoRi) initiative seeks to accelerate a paradigm shift in rare disease diagnosis by reimagining the tools, molecular technologies and analytical approaches used to identify the causal gene(s) and/or variant(s) underlying

Deadline
Oct 31, 2026
Funding
Estimated total program funding: $3,000,000
Check fit and official source →
OPENHealth & Medical

GREGoRi Data Coordination and Outreach Center (U01, Clinical Trials Not Allowed)

National Institutes of Health

The Genomics Research to Elucidate the Genetics of Rare Diseases:innovation (GREGoRi) initiative seeks to accelerate a paradigm shift in rare disease diagnosis by reimagining the tools, molecular technologies and analytical approaches used to identify the causal gene(s) and/or variant(s) underlying

Deadline
Oct 31, 2026
Funding
Estimated total program funding: $2,000,000
Check fit and official source →
OPENHealth & Medical

HEAL Initiative: Whole Joint Health Program (R61/R33 Clinical Trial Required)

National Institutes of Health

The NIH Helping to End Addiction Long-term® (HEAL) Initiative is releasing this Notice of Funding Opportunity (NOFO) to support a phased mechanistic clinical research program focusing on understudied biological mechanisms that drive joint pain. The phased projects supported by this program (of

Deadline
Oct 31, 2026
Funding
See official notice
Check fit and official source →
OPENHealth & Medical

BJA FY 2026 Comprehensive Opioid, Stimulant, and Substance Use Program (COSSUP) Training and Technical Assistance (TTA)

Bureau of Justice Assistance

This is a notice of funding opportunity (NOFO) for the Comprehensive Opioid Stimulant and Substance Use Program (COSSUP) Training and Technical Assistance (TTA). This opportunity will provide training and technical assistance to BJA COSSUP grantees to address technical operational challenges to impr

Deadline
Nov 3, 2026
Funding
Up to $2,000,000
Check fit and official source →
OPENHealth & Medical

Clinical Observational (CO) Studies in Musculoskeletal, Rheumatic, and Skin Diseases (R01 Clinical Trial Not Allowed)

National Institutes of Health

This Clinical Observational (CO) Studies in Musculoskeletal, Rheumatic, and Skin Diseases (R01 Clinical Trial Not Allowed) PAR, was re-issued as a result of the Simplifying Review of Research Project Grant Applications [link: https://grants.nih.gov/policy-and-compliance/policy-topics/peer-review/sim

Deadline
Nov 3, 2026
Funding
See official notice
Check fit and official source →
OPENHealth & Medical

Exploratory Clinical Trial Grants in Arthritis and Musculoskeletal and Skin Diseases (R61 Clinical Trial Required)

National Institutes of Health

This Exploratory Clinical Trial Grants in Arthritis and Musculoskeletal and Skin Diseases (R61 Clinical Trial Required) PAR, a re-issue of PAR-24-035, was re-issued as a result of the Simplifying Review of Research Project Grant Applications [link: https://grants.nih.gov/policy-and-compliance/policy

Deadline
Nov 3, 2026
Funding
See official notice
Check fit and official source →
OPENSmall Business & Startups

2026 California Nutrition Incentive Program

CA Department of Food and Agriculture

The 2026 CNIP RFP is focused on increasing California-grown fresh fruit and vegetable purchases at Certified Farmers’ Markets and California Small Businesses* by shoppers using CalFresh (SNAP) benefits and sustaining proposals in high need areas.

Deadline
Nov 4, 2026
Funding
Award range: $50,000.00–$12,500,000.00 · Program total: $13,500,000.00
Check fit and official source →
OPENSmall Business & Startups

Focal award: EPSRC and MHCLG Fire Engineering Skills Hub (Grant)

UK Government

Word limit: 550 In plain English, provide a summary we can use to identify the most suitable experts to assess your application. We usually make this summary publicly available on external-facing websites, therefore do not include any confidential or sensitive information. Make it suitable for a variety of readers, for

Deadline
Nov 4, 2026
Funding
See official notice
Check fit and official source →
OPENEducation

Developing novel theory and methods for understanding the genetic architecture of complex human traits (R01 Clinical Trial Not Allowed)

National Institutes of Health

The goal of this NOFO is to support applications for novel theory and methods development that enable better understanding of how genetic and non-genetic factors contribute to complex trait variation across individuals, families, and populations. Approaches should be interdisciplinary drawing from t

Deadline
Nov 6, 2026
Funding
See official notice
Check fit and official source →
OPENHealth & Medical

Secondary Analysis and Integration of Existing Data to Elucidate Cancer Risk and Related Outcomes (R01 Clinical Trial Not Allowed)

National Institutes of Health

Through this Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) along with other participating Institutes encourages submission of applications proposing to conduct secondary data analysis and integration of existing datasets and database resources, with the ultimate aim to el

Deadline
Nov 7, 2026
Funding
Estimated total program funding: $350,000
Check fit and official source →
OPENSmall Business & Startups

UKAEA (FOSTER) Fusion Sector Access Bursaries Cohort 2

UK Government

These bursaries are delivered by the FOSTER programme at UKAEA, which looks to create a pool of fusion-ready individuals able to join the growing fusion sector. The high-level project strategy to “implement a mechanism to provide bursaries to support the studies of students from under-represented backgrounds on courses

Deadline
Nov 10, 2026
Funding
See official notice
Check fit and official source →
OPENHealth & Medical

Early-Stage Innovative Technology Development for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed)

National Institutes of Health

Through this Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) solicits grant applications proposing to develop innovative technologies offering new capabilities for the molecular or cellular characterization of cancer or for improved handling and quality control of biospecim

Deadline
Nov 11, 2026
Funding
Estimated total program funding: $5,100,000
Check fit and official source →
OPENHealth & Medical

Advanced Development and Validation of Emerging Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)

National Institutes of Health

Through this Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) invites grant applications proposing exploratory research projects focused on further development and technical validation of emerging technologies offering novel capabilities for the molecular or cellular charact

Deadline
Nov 11, 2026
Funding
Estimated total program funding: $5,900,000
Check fit and official source →
OPENHealth & Medical

Amyotrophic Lateral Sclerosis (ALS) Intermediate Patient Population Expanded Access (U01 Clinical Trial Required)

National Institutes of Health

The purpose of this Notice of Funding Opportunity (NOFO) is to solicit applications for the conduct of scientific research utilizing data from expanded access (EA) for investigational drugs or biological products as described in section 561 of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 360b

Deadline
Nov 11, 2026
Funding
Estimated total program funding: $40,000,000
Check fit and official source →
OPENHealth & Medical

Pilot Projects to Enhance the Human Virome Program (R03 Clinical Trials Not Allowed)

National Institutes of Health

The Common Fund Human Virome Program (HVP) aims to extensively and comprehensively characterize the "healthy" human virome (the collection of viruses that normally reside inside the human body without evidence of disease) and create tools, models, and methods that will enable an in-depth s

Deadline
Nov 11, 2026
Funding
Estimated total program funding: $2,000,000
Check fit and official source →
OPENHealth & Medical

Data Coordinating Center for the Aging and Alzheimer’s Disease Mouse Brain Atlas (AD-MBA) (U24 Clinical Trial Not Allowed)

National Institutes of Health

This Notice of Funding Opportunity (NOFO) invites applications proposing a Data Coordinating Center that integrates and disseminates multiscale mouse brain datasets for the aging and Alzheimer's disease (AD) research community. The Data Coordinating Center will establish the Aging and AD Mouse

Deadline
Nov 11, 2026
Funding
Estimated total program funding: $2,500,000
Check fit and official source →
OPENHealth & Medical

Infectious Diseases Clinical Trials Network (IDCTN) (UM1 Clinical Trial Required)

National Institutes of Health

The purpose of this notice of funding opportunity (NOFO) is to solicit applications for an Infectious Diseases Clinical Trials Network (IDCTN). The IDCTN, comprised of the Clinical Trial Evaluation Units (CTEUs) and a Network Coordination Center (NCC), supports the evaluation of interventions for em

Deadline
Nov 11, 2026
Funding
Estimated total program funding: $10,000,000
Check fit and official source →
OPENHealth & Medical

Clinical Research Network on Antimicrobial Resistance (UM1 Clinical Trial Required)

National Institutes of Health

The purpose of this notice of funding opportunity (NOFO) is to support a Clinical Research Network (CRN) on Antimicrobial Resistance (AMR). The program aims to design, implement, and manage clinical research that addresses pivotal clinical questions related to AMR through a coordinated and integrate

Deadline
Nov 11, 2026
Funding
Estimated total program funding: $18,000,000
Check fit and official source →
OPENSmall Business & Startups

UKRI Translation: MRC Impact Acceleration Awards (Grant)

UK Government

Word limit: 550In plain English, provide a summary we can use to identify the most suitable experts to assess your application. We usually make this summary publicly available on external-facing websites, therefore do not include any confidential or sensitive information. Make it suitable for a variety of readers, for e

Deadline
Nov 12, 2026
Funding
See official notice
Check fit and official source →
OPENHealth & Medical

NCCIH Natural Product Early Phase Clinical Trial Award (R33 Clinical Trial Required)

National Institutes of Health

This Notice of Funding Opportunity (NOFO) encourages applications for investigator-initiated, early phase, clinical trials of natural products (i.e., botanicals, dietary supplements, and probiotics), which have a strong scientific premise to justify further clinical testing. For this NOFO, natural p

Deadline
Nov 14, 2026
Funding
Estimated total program funding: $1,050,000
Check fit and official source →

Strong fit signals

  • The health need is evidenced
  • Regulatory milestones are understood
  • The work fits the program stage

Requirements to verify

  • Clinical and human-subject requirements
  • Allowable product-development costs

How to use this shortlist

Open the official notice for each candidate and build a simple go/no-go table covering legal applicant type, geography, project purpose, award range, match, registrations and submission time zone. Eliminate any program that fails a mandatory condition before spending time on narrative drafting.

Frequently asked questions

Who should use this health grants for small businesses page?

Health ventures and small biomedical companies. Treat the directory match as a discovery signal and confirm the controlling eligibility language on the funder's notice.

How are opportunities selected?

The page applies a fixed combination of structured applicant, focus, source, award or deadline signals to current directory records. It does not broaden the result with unrelated keywords.

Does a listing mean my organization is eligible?

No. A match helps build a shortlist; the official notice, application package and funder guidance control eligibility and allowable costs.